An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-23
DOI
10.3389/fphar.2021.715253
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Associations of Genetic Variants Contributing to Gut Microbiota Composition in Immunoglobin A Nephropathy
- (2021) Jia-Wei He et al. mSystems
- Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
- (2021) Wai Han Yiu et al. Frontiers in Physiology
- Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model
- (2021) Vincenzo Di Leo et al. Journal of Personalized Medicine
- POS-830 NEFECON FOR THE TREATMENT OF IgA NEPHROPATHY IN PATIENTS AT RISK OF PROGRESSING TO END-STAGE RENAL DISEASE: THE NEFIGARD PHASE 3 TRIAL RESULTS
- (2021) J. BARRATT et al. Kidney International Reports
- Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway
- (2020) Ming Xia et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study
- (2020) Xiaofang Hu et al. BMC Nephrology
- T lymphocytes in IgA nephropathy (Review)
- (2020) Yuyan Tang et al. Experimental and Therapeutic Medicine
- Hydroxychloroquine in rheumatic autoimmune disorders and beyond
- (2020) Eliise Laura Nirk et al. EMBO Molecular Medicine
- Budesonide versus systemic corticosteroids in IgA Nephropathy
- (2020) Gener Ismail et al. MEDICINE
- MO039THE 24-WEEK INTERIM ANALYSIS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY OF ATACICEPT IN PATIENTS WITH IGA NEPHROPATHY AND PERSISTENT PROTEINURIA
- (2020) Jonathan Barratt et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy
- (2020) Richard Lafayette et al. Kidney International Reports
- Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy
- (2020) Ming Li et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
- (2020) Ruijuan Dong et al. Frontiers in Cellular and Infection Microbiology
- Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population
- (2020) ZhengXia Zhong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy
- (2019) James R. Myette et al. KIDNEY INTERNATIONAL
- Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial
- (2019) Li-Jun Liu et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy
- (2019) Miki Takahara et al. CELLULAR IMMUNOLOGY
- Risankizumab: First Global Approval
- (2019) Kate McKeage et al. DRUGS
- Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats
- (2019) Lixia Bai et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study
- (2019) Simon Jarrick et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- (2019) Fernando C. Fervenza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renoprotective effects of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via suppressing NF-κB signaling and NLRP3 inflammasome activation by exosomes in rats
- (2019) Lixia Bai et al. BIOCHEMICAL PHARMACOLOGY
- The role of complement in IgA nephropathy
- (2019) Agustin Tortajada et al. MOLECULAR IMMUNOLOGY
- Autophagy in Immune-Related Renal Disease
- (2019) Xin Ye et al. Journal of Immunology Research
- Predictive value of mesangial C3 and C4d deposition in IgA nephropathy
- (2019) Ki Heon Nam et al. CLINICAL IMMUNOLOGY
- TGF-β1 inhibits the autophagy of podocytes by activating mTORC1 in IgA nephropathy
- (2019) Xing Mao et al. EXPERIMENTAL CELL RESEARCH
- The Role of IgA in the Pathogenesis of IgA Nephropathy
- (2019) Martina Perše et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IgA1 deposition may induce NLRP3 expression and macrophage transdifferentiation of podocyte in IgA nephropathy
- (2019) Wei Peng et al. Journal of Translational Medicine
- BAFF is involved in the pathogenesis of IgA nephropathy by activating the TRAF6/NF‑κB signaling pathway in glomerular mesangial cells
- (2019) Yingjie Cao et al. Molecular Medicine Reports
- Treatment with Bifidobacterium longum 51A attenuates intestinal damage and inflammatory response in experimental colitis
- (2019) F.A. Abrantes et al. Beneficial Microbes
- Effects of Hydroxychloroquine on Proteinuria in Immunoglobulin A Nephropathy
- (2018) Ya-Zi Yang et al. AMERICAN JOURNAL OF NEPHROLOGY
- Tonsillitis exacerbates renal injury in IgA nephropathy through promoting Th22 cells chemotaxis
- (2018) Lu Gan et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy
- (2018) Lu Gan et al. RENAL FAILURE
- Insights into the Role of Mucosal Immunity in IgA Nephropathy
- (2018) Yue-miao Zhang et al. Clinical Journal of the American Society of Nephrology
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- Epidemiology of IgA Nephropathy: A Global Perspective
- (2018) Francesco Paolo Schena et al. SEMINARS IN NEPHROLOGY
- The Gut-Renal Connection in IgA Nephropathy
- (2018) Rosanna Coppo SEMINARS IN NEPHROLOGY
- Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy
- (2018) Stephen McAdoo et al. SEMINARS IN NEPHROLOGY
- T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target
- (2018) Jakub Ruszkowski et al. Clinical and Experimental Nephrology
- Schisandrin B Improves the Renal Function of IgA Nephropathy Rats Through Inhibition of the NF-κB Signalling Pathway
- (2018) Jian-Hua Qin et al. INFLAMMATION
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
- (2018) Howard Trachtman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Losartan and Dexamethasone may inhibit chemotaxis to reduce the infiltration of Th22 cells in IgA nephropathy
- (2017) Chenggen Xiao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases
- (2017) Eileen Samy et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy
- (2017) Ruitong Gao et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Rapamycin Induces Autophagy and Reduces the Apoptosis of Podocytes Under a Stimulated Condition of Immunoglobulin A Nephropathy
- (2017) Shikai Liang et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
- (2017) Bengt C Fellström et al. LANCET
- Glomerular disease: Targeted steroid therapy for IgA nephropathy
- (2017) Richard J. Glassock Nature Reviews Nephrology
- New insights into the pathogenesis of IgA nephropathy
- (2017) See Cheng Yeo et al. PEDIATRIC NEPHROLOGY
- Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date
- (2017) Aleksander Lenert et al. Drug Design Development and Therapy
- NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy
- (2017) Yu-Ling Tsai et al. Scientific Reports
- Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease
- (2016) Radko Komers et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- How many podocyte autophagosomes are there in immunoglobulin A nephropathy and idiopathic membranous nephropathy?
- (2016) Shikai Liang et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy
- (2016) S. M. Lechner et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy
- (2016) Masahiro Muto et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
- (2016) Richard A. Lafayette et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Primary glomerulonephritides
- (2016) Jürgen Floege et al. LANCET
- Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
- (2016) Ya-Ling Zhai et al. MEDICINE
- Rituximab therapy for IgA nephropathy
- (2016) Jürgen Floege Nature Reviews Nephrology
- Rituximab for recurrent IgA nephropathy in kidney transplantation: A report of three cases and proposed mechanisms
- (2016) Wiwat Chancharoenthana et al. NEPHROLOGY
- Bacterial IgA protease-mediated degradation of agIgA1 and agIgA1 immune complexes as a potential therapy for IgA Nephropathy
- (2016) Li Wang et al. Scientific Reports
- Icariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b/Nlrp3 pathway
- (2016) Lei Zhang et al. FEBS Open Bio
- The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
- (2016) Barbora Knoppova et al. Frontiers in Immunology
- IgA nephropathy
- (2016) Kar Neng Lai et al. Nature Reviews Disease Primers
- Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy
- (2015) Ya-Ping Chang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of IgA receptors in the pathogenesis of IgA nephropathy
- (2015) Sebastian M. Lechner et al. JOURNAL OF NEPHROLOGY
- Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression
- (2015) Stephen P. McAdoo et al. KIDNEY INTERNATIONAL
- New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
- (2015) Riccardo Magistroni et al. KIDNEY INTERNATIONAL
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- (2015) Thomas Rauen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy
- (2015) Yang Gyun Kim et al. PLoS One
- The emerging role of the inflammasome in kidney diseases
- (2014) Anthony Chang et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Cytokines Alter IgA1O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes
- (2014) Hitoshi Suzuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Combined Role of Galactose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for IgA Nephropathy
- (2014) R. Schmitt et al. JOURNAL OF IMMUNOLOGY
- Endothelin and endothelin antagonists in chronic kidney disease
- (2014) Donald E Kohan et al. KIDNEY INTERNATIONAL
- TLR9 and BAFF: Their expression in patients with IgA nephropathy
- (2014) WEIWEI LI et al. Molecular Medicine Reports
- A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy
- (2014) T. Kawamura et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Eculizumab treatment for rescue of renal function in IgA nephropathy
- (2014) Therese Rosenblad et al. PEDIATRIC NEPHROLOGY
- Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
- (2014) Maria De Angelis et al. PLoS One
- Inhibitors of switch kinase ‘spleen tyrosine kinase’ in inflammation and immune-mediated disorders: A review
- (2013) Maninder Kaur et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- C3a, C5a Renal Expression and Their Receptors are Correlated to Severity of IgA Nephropathy
- (2013) Lu Liu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features
- (2013) Gang Xin et al. JOURNAL OF NEPHROLOGY
- IgA Nephropathy
- (2013) Robert J. Wyatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osthole Mitigates Progressive IgA Nephropathy by Inhibiting Reactive Oxygen Species Generation and NF-κB/NLRP3 Pathway
- (2013) Kuo-Feng Hua et al. PLoS One
- Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
- (2012) Laureline Berthelot et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Spleen Tyrosine Kinase Is Important in the Production of Proinflammatory Cytokines and Cell Proliferation in Human Mesangial Cells following Stimulation with IgA1 Isolated from IgA Nephropathy Patients
- (2012) M. J. Kim et al. JOURNAL OF IMMUNOLOGY
- An update on the pathogenesis and treatment of IgA nephropathy
- (2012) Joanna K. Boyd et al. KIDNEY INTERNATIONAL
- Decreased Circulating C3 Levels and Mesangial C3 Deposition Predict Renal Outcome in Patients with IgA Nephropathy
- (2012) Seung Jun Kim et al. PLoS One
- Chapter 10: Immunoglobulin A nephropathy
- (2012) Kidney International Supplements
- Mice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathy
- (2011) Douglas D. McCarthy et al. JOURNAL OF CLINICAL INVESTIGATION
- The Pathophysiology of IgA Nephropathy
- (2011) H. Suzuki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria
- (2011) H. K. Smerud et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy
- (2010) Mai T. Vuong et al. KIDNEY INTERNATIONAL
- Brief Communication: Immunoglobulin A1 protease: A new therapeutic candidate for immunoglobulin A nephropathy
- (2010) LIN-SHEN XIE et al. NEPHROLOGY
- Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity
- (2009) Hitoshi Suzuki et al. JOURNAL OF CLINICAL INVESTIGATION
- Correlation of Autophagy Type in Podocytes with Histopathological Diagnosis of IgA Nephropathy
- (2009) S. Sato et al. PATHOBIOLOGY
- Effect of Tonsillectomy Plus Steroid Pulse Therapy on Clinical Remission of IgA Nephropathy: A Controlled Study
- (2008) H. Komatsu et al. Clinical Journal of the American Society of Nephrology
- Role of Rituximab Therapy in Glomerulonephritis
- (2008) D. Jayne JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
- (2008) I. H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microbial IgA Protease Removes IgA Immune Complexes from Mouse Glomeruli In Vivo: Potential Therapy for IgA Nephropathy
- (2007) Michael E. Lamm et al. AMERICAN JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started